Guess What Else is NOT a Top Priority of the FDA?

by Nolan and Auerbach on July 12, 2006

Answer: Monitoring postmarketing study commitments.

The FDA lacks an effective system for monitoring postmarketing study commitments.  See the latest OIG Report, dated June 2006.

Leave a Comment